Industry Focus

Beaten-up biotech has some work to do to restore investor confidence. Here's how Gilead Sciences, Valeant Pharmaceuticals, and the entire industry can get back on track in 2017.

 

Direct download: 20170104_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EDT